http://www.fpnotebook.com/
ParoxetineAka: Paxil, Paroxetine hydrochloride, Pexeva, Paroxetine mesylate
- Mechanism
- Indications
- Major Depression
- Comorbid Generalized anxiety or Panic Attacks
- Obsessive Compulsive Disorder
- Suppression of premature ejaculation
- Social Anxiety Disorder or Social Phobia
- Post-Traumatic Stress Disorder
- Background
- Cost: $81 per month
- Preparations
- Paxil (Paroxetine hydrochloride)
- Generic Paxil is available in United States in 2003
- Tablets (lower doses scored): 10, 20, 30, and 40 mg
- Oral Suspension: 10 mg/5 ml
- Paxil CR Tablets: 12.5, 25, and 37.5 mg
- Marketed as reducing GI upset with standard Paxil
- Must be swallowed whole without chewing
- Pexeva (Paroxetine mesylate)
- Likely has similar activity to Paxil but not proven
- Significantly less expensive than Paxil
- Paxil (Paroxetine hydrochloride)
- Dosing: Paxil
- Start
- Adults: 20 mg PO qhs
- Elderly: 10 mg qd
- Titrate
- Adults: Increase by 10 mg every 2 weeks
- Maximum: 60 mg PO qhs
- Start
- Mechanism
- Selective Serotonin Reuptake Inhibitor (SSRI)
- Increased Norepinephrine reuptake inhibitor activity
- Increased anticholinergic activity
- Pharmacokinetics
- Half Life: 1 day (shorter than most other SSRIs)
- Drug Interactions
- Inhibits Cytochrome P450-2D6
- Raises Warfarin (Coumadin) levels and associated INR
- Raises Tricyclic Antidepressant levels
- Highly protein bound
- Interacts with other protein bound medications
- Allow 2 week wash-out prior to starting MAO inhibitor
- Adverse Effects
- Anticholinergic side effects (Sedation, Constipation)
- Avoid in elderly with cognitive disorders
- Sedating on the Sedation to excitation continuum
- Most sedating of the SSRIs (administer at bedtime)
- Some patients may have paradoxical activation
- Sexual Dysfunction (inhibits nitric oxide synthetase)
- See Antidepressant Induced Sexual Dysfunction
- More common than with Fluoxetine or Sertraline
- Dysesthesia (skin Paresthesias)
- Dry Mouth
- Constipation
- Antidepressant Withdrawal on stopping medication
- Reduce dose by 10 mg per day every 5-7 days
- Taper down to 5-10 mg before discontinuing
- Less anxiety (more Anxiolytic) than other SSRIs
- Similar to Serzone on this spectrum
- Weight gain
- More common than with Fluoxetine or Sertraline
- Anticholinergic side effects (Sedation, Constipation)
- Precautions
- Use caution in Pediatric Depression
- Use may be associated with higher Suicide Risk
- Use caution in Pediatric Depression
- Resources
- Paxil Website (GlaxoSmithKline)
Paroxetine (C0070122) | |
|---|---|
| Definition (MSH) | A serotonin uptake inhibitor that is effective in the treatment of depression. |
| Definition (CSP) | serotonin uptake inhibitor used in the treatment of depression. |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D017374 |
| English | Paroxetine, PAROXETINE PREPARATION |
| Spanish | paroxetina |
| Parent Concepts | piperidine (C0031959), Antidepressive Agents (C0003289), Serotonin Uptake Inhibitors (C0162758), Piperidines (C0031960), [CN609] ANTIDEPRESSANTS, OTHER (C0973506), Selective serotonin re-uptake inhibitor (C0360105), Drug allergen (C1320237), Anti-Anxiety Agents (C0040616) |
| Sources | AOD, CSP, LNC, MSH, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Paxil (C0376414) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D017374 |
| English | Paxil |
| Sources | CSP, MSH, NCI, PDQ, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
Pexeva (C1602496) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| English | Pexeva |
| Sources | NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
